Cision PR Newswire

Ascletis’ Oral Small Molecule GLP-1, ASC30, Demonstrated Placebo-Adjusted HbA1c Reduction of 1.7% at 12 Weeks from Its U.S. Phase II Study in Participants with...

- ASC30 reduced HbA1c by a placebo-adjusted 1.7%, 1.6% and 1.7% from baseline for 40 mg, 60 mg and 80 mg, respectively, at 12 weeks, the...

FORBES TRAVEL GUIDE UNVEILS 2025 STAR AWARDS

Winners Deliver Authentic Experiences, Enhanced Well-Being and Unforgettable Moments ~ FTG Becomes the First Rating System to Honor Cruise Ship Restaurants ...

Daqo New Energy to Announce Unaudited Results for the Fourth Quarter and Fiscal Year 2024 on February 27, 2025

SHANGHAI, Feb. 12, 2025 /PRNewswire/ -- Daqo New Energy Corp. (NYSE: DQ) ("Daqo New Energy" or the "Company"), a leading manufacturer of high-purity polysilicon...

Wanda Hotels & Resorts Marks Global Expansion with Grand Opening of Wanda Jin Residences The Ease Sierra Bangkok

BANGKOK, Feb. 12, 2025 /PRNewswire/ -- On January 9, 2025, Wanda Jin Residences The Ease Sierra Bangkok, situated in the heart of Thailand's capital,...